Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Austria | IgE | 35 | 31.420 | 20141020, Guhsl EE
| 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 6.430 | 20130111, Ott H
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.900 | 20130912, Lacerda Araujo LM
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 5.300 | 20131020, van Rhijn BD
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 5.710 | 20130605, Simon D
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 95.000 | 20130401, Berneder M
| 6.2 - General Population (Adults) | 2012 | Sweden | BPT | 371 | 1.080 | 20120528, Patelis A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 14.140 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 5.210 | 20120528, Patelis A
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Austria | IgE | 19 | 6.000 | 20110829, DallAntonia F
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 0.990 | 20100301, Scala E
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 11.620 | 20101214, Gadisseur R
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 27.020 | 20090826, Ebo DG
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Switzerland | IgE | 24 | 75.000 | 20091005, Bauermeister K
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 30.000 | 20091121, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 20 | 35.000 | 20091005, Bauermeister K
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2005 | Germany | HRT | 20 | 75.000 | 20050218, Erdmann SM
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2000 | Switzerland | IgE | 22 | 59.100 | 2000, Luttkopf D
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2000 | Austria | IgE (IB) | 10 | 100.000 | 2000, Hoffmann-Sommergruber K
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1999 | Switzerland | SPT | 24 | 100.000 | 1999a, Hoffmann-Sommergruber K
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1999 | France | SPT | 11 | 18.200 | 1999a, Hoffmann-Sommergruber K
| 5.3.2 - Source Exposed (Symptoms, high IgE) | 1996 | Germany | IgE | 60 | 33.000 | 1996, Jankiewicz A
|
|